(Q38876012)

7 September 2017

title

Antiretroviral therapy improves renal function among HIV-infected Ugandans (English)

1 reference

7 September 2017

0 references

anti-retroviral agent

0 references

4

John T Brooks

1 reference

7 September 2017

Philip J Peters

1

1 reference

7 September 2017

David M Moore

2

1 reference

7 September 2017

Jonathan Mermin

3

1 reference

7 September 2017

Robert Downing

5

1 reference

7 September 2017

Willy Were

6

1 reference

7 September 2017

Aminah Kigozi

7

1 reference

7 September 2017

Kate Buchacz

8

1 reference

7 September 2017

Paul J Weidle

9

1 reference

7 September 2017

language of work or name

English

0 references

publication date

9 July 2008

1 reference

7 September 2017

number of pages

5

1 reference

inferred from page(s)

published in

Kidney International

1 reference

7 September 2017

volume

74

1 reference

7 September 2017

issue

7

1 reference

7 September 2017

page(s)

925-929

1 reference

Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.305

7 January 2021

The impact of HIV on chronic kidney disease outcomes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.305

7 January 2021

HIV-1 and HIV-Associated Nephropathy 25 Years Later

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.305

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.305

7 January 2021

A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.305

7 January 2021

Renal disease in an antiretroviral-naïve HIV-infected outpatient population in Western Kenya.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.305

7 January 2021

Renal disease in HIV-seropositive patients in Nigeria: an assessment of prevalence, clinical features and risk factors

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.305

7 January 2021

Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.305

7 January 2021

Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.305

7 January 2021

Observations on HIV-associated renal disease in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.305

7 January 2021

Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.305

7 January 2021

Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.305

7 January 2021

Variation in incidence of indinavir-associated nephrolithiasis among HIV-positive patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.305

7 January 2021

Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.305

7 January 2021

Predictors of proteinuria and renal failure among women with HIV infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.305

7 January 2021

HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.305

7 January 2021

Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.305

7 January 2021

The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.305

7 January 2021

Antiretroviral therapy in the treatment of HIV-associated nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.305

7 January 2021

HIV-1-associated nephropathy and response to highly-active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.305

7 January 2021

Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.305

7 January 2021

Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.305

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.305

7 January 2021

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.305

7 January 2021

Identifiers

DOI

10.1038/KI.2008.305

1 reference

Dimensions Publication ID

7 September 2017

1048706381

0 references

1 reference